Us Bancorp \De\ Corbus Pharmaceuticals Holdings, Inc. Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$1.27 - $3.42 $254 - $684	-200 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$0.94 - $1.89 $132 - $266	-141 Reduced 41.35%	200 $0
Q3 2020 Nov 10, 2020	BUY	$1.5 - $9.38 $300 - $1,876	200 Added 141.84%	341 $1,000
Q2 2020 Aug 07, 2020	BUY	$4.79 - $8.39 $675 - $1,182	141 New	141 $1,000
Q2 2018 Aug 08, 2018	SELL	$5.05 - $6.8 $7,575 - $10,200	-1,500 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$5.6 - $9.25 $3,919 - $6,475	700 Added 87.5%	1,500 $9,000
Q3 2017 Nov 13, 2017	BUY	$5.75 - $7.75 $4,600 - $6,200	800	800 $6,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.